Form D · Other Health Care
In Vitro Sciences, LLC
Avon, CT · CIK 0001790997
Offering snapshot reported Oct 16, 2019 · SEC filing
- Reported sold
- $31.5M Offering amount: $31.5M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 1, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 16, 2019 | Initial | $31,500,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-351132
Source: Form D, filed Oct 16, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrea Balogh | Executive |
| David Finley | Director |
| Gregg Osenkowski | Director |
| Michael Pascetta | Executive |
| Brian Pskowski | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
22 Waterville Road
Avon, CT, 06001-2066
Avon, CT, 06001-2066